Ratings by Chardan (Daniil Gatauli)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/8/2022 Oyster Point Pharma OYST Downgrade Neutral
(Buy)
8.35
(11.17)
33.77% Details